Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,180,266 papers from all fields of science
Search
Sign In
Create Free Account
pM-81 Monoclonal Antibody
Known as:
pM-81
A type of monoclonal antibody used in cancer detection or therapy. Monoclonal antibodies are laboratory-produced substances that can locate and bind…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
antigen binding
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
A combination of CD34 selection and complement-mediated immunopurging (anti-CD15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells.
M. Nimgaonkar
,
A. Kemp
,
J. Lancia
,
E. Ball
Journal of Hematotherapy
1996
Corpus ID: 34143688
Autologous bone marrow transplantation (ABMT) for acute myeloid leukemia (AML) in first complete remission (CR) results in a…
Expand
1996
1996
Evaluation of monoclonal antibody-mediated anti-acute myeloid leukemia immunotherapy in a SCID/hu model.
R. Zhong
,
A. Donnenberg
,
+8 authors
E. Ball
Leukemia research : a Forum for Studies on…
1996
Corpus ID: 24326613
1995
1995
Homologous restriction of complement‐mediated cell lysis can be markedly enhanced by blocking decay‐accelerating factor
Rui‐Kon Zhong
,
R. Kozii
,
E. Ball
British Journal of Haematology
1995
Corpus ID: 34097523
Summary. Regulation of complement (C′) dependent lysis of cells is attributed to certain membrane proteins. One of these is decay…
Expand
1994
1994
A combination of anti-CD15 monoclonal antibody PM-81 and 4-hydroperoxycyclophosphamide augments tumor cytotoxicity while sparing normal progenitor cells.
J. Rubin
,
V. Malley
,
E. Ball
Journal of Hematotherapy
1994
Corpus ID: 41216880
A cyclophosphamide congener, 4-hydroperoxycyclophosphamide (4HC), has been used to purge bone marrow (BM) of residual leukemia…
Expand
1991
1991
Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads.
J. Vredenburgh
,
W. Simpson
,
V. Memoli
,
E. Ball
Cancer Research
1991
Corpus ID: 9935547
The CD15 carbohydrate antigen, lacto-N-fucopentaose III is expressed on a variety of human cancer cells including acute myeloid…
Expand
1991
1991
Expression of the CD15 antigen on normal and leukemic myeloid cells: effects of neuraminidase and variable detection with a panel of monoclonal antibodies.
E. Ball
,
Lamia M. Schwarz
,
C. Bloomfield
Molecular Immunology
1991
Corpus ID: 29397949
1990
1990
Autologous bone marrow transplantation for acute myeloid leukemia following in vitro treatment with neuraminidase and monoclonal antibodies.
E. Ball
,
J. Vredenburgh
,
+4 authors
K. Troy
Bone Marrow Transplantation
1990
Corpus ID: 1794630
Although monoclonal antibodies (MoAbs) to CD15, especially PM-81, react with leukemic blasts from the majority of patients with…
Expand
1985
1985
Monoclonal antibody-mediated cytotoxicity of human myeloid leukemia cells: an in vitro model for estimating efficiency and optimal conditions for cytolysis.
A. Howell
,
E. Ball
Blood
1985
Corpus ID: 33273606
Monoclonal antibodies (MoAbs) to myeloid differentiation antigens have a potential use in purging bone marrow of leukemia cells…
Expand
Highly Cited
1984
Highly Cited
1984
Monoclonal antibodies PMN 6, PMN 29, and PM-81 bind differently to glycolipids containing a sugar sequence occurring in lacto-N-fucopentaose III.
John L. Magnani
,
Edward D. Ball
,
Michael W. Fanger
,
Sen-itiroh Hakomori
,
Victor Ginsburg
Archives of Biochemistry and Biophysics
1984
Corpus ID: 25067143
Highly Cited
1983
Highly Cited
1983
A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
E. Ball
,
R. Graziano
,
M. Fanger
Journal of Immunology
1983
Corpus ID: 25081862
A murine hybridoma-derived monoclonal antibody, PM-81, was obtained from a fusion of cells of the NS-1 myeloma cell line with…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE